Trial Profile
A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Brain metastases; Breast cancer
- Focus Therapeutic Use
- 31 Jan 2018 New trial record